8 results
10-K
2021 FY
CADL
Candel Therapeutics Inc
29 Mar 22
Annual report
8:46am
that T cells can be unleashed to attack cancer cells and that profound clinical benefit can be achieved, but this benefit accrues only to a minority
424B4
CADL
Candel Therapeutics Inc
28 Jul 21
Prospectus supplement with pricing info
4:02pm
can be unleashed to attack cancer cells and that profound clinical benefit can be achieved, but this benefit accrues only to a minority of patients
S-1/A
mr2uoj6
16 Jul 21
IPO registration (amended)
6:07am
S-1
5yteckjq 5y8
25 Jun 21
IPO registration
5:28pm
DRS/A
c8bt5zmntr4
31 Mar 21
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next